Prevalence of chronic kidney disease in Western Australia, 2010-2020.

IF 2.4 3区医学 Q1 MEDICINE, GENERAL & INTERNAL

BMJ Open Pub Date : 2025-01-28 DOI:10.1136/bmjopen-2024-092320

Kanika Mehta, Sean Randall, Crystal Man Ying Lee, Elizabeth Thomas, Aron Chakera, Kevin Chai, Mohamed Estai, Madison Frith, Delia Hendrie, James Boyd, Suzanne Robinson

{"title":"Prevalence of chronic kidney disease in Western Australia, 2010-2020.","authors":"Kanika Mehta, Sean Randall, Crystal Man Ying Lee, Elizabeth Thomas, Aron Chakera, Kevin Chai, Mohamed Estai, Madison Frith, Delia Hendrie, James Boyd, Suzanne Robinson","doi":"10.1136/bmjopen-2024-092320","DOIUrl":null,"url":null,"abstract":"Objective: To assess the prevalence and trends of chronic kidney disease (CKD) in Western Australia (WA) from 2010 to 2020 using linked pathology data.Design: A retrospective observational cohort study using linked de-identified data from WA pathology providers, hospital morbidity records and mortality records.Setting: A Western Australian population-based study.Participants: All individuals aged 18 years and older with at least one serum creatinine test.Primary outcome measure: CKD status as determined by estimated glomerular filtration rate and urine albumin-creatinine ratio.Results: Analysing data from 2 501 188 individuals, there was a significant increase in age-sex standardised CKD prevalence from 4.7% in 2010 to 6.0% in 2020, with annual average percentage change of 3.0% (95% CI: 2.3% to 3.7%). Prevalence of CKD stages 3 and above was 4.8% in 2020. Higher CKD prevalence was observed in regional and remote areas compared with major cities, and among individuals in the most socioeconomically disadvantaged quintiles. Sensitivity analysis indicated minor impacts from data exclusions and methodological choices.Conclusions: CKD prevalence in WA has been steadily increasing, reflecting broader Australian trends. The study highlights significant disparities in CKD prevalence based on age, socioeconomic status and geographic remoteness.","PeriodicalId":9158,"journal":{"name":"BMJ Open","volume":"15 1","pages":"e092320"},"PeriodicalIF":2.4000,"publicationDate":"2025-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11781091/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMJ Open","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/bmjopen-2024-092320","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}

引用次数: 0

Abstract

Objective: To assess the prevalence and trends of chronic kidney disease (CKD) in Western Australia (WA) from 2010 to 2020 using linked pathology data.

Design: A retrospective observational cohort study using linked de-identified data from WA pathology providers, hospital morbidity records and mortality records.

Setting: A Western Australian population-based study.

Participants: All individuals aged 18 years and older with at least one serum creatinine test.

Primary outcome measure: CKD status as determined by estimated glomerular filtration rate and urine albumin-creatinine ratio.

Results: Analysing data from 2 501 188 individuals, there was a significant increase in age-sex standardised CKD prevalence from 4.7% in 2010 to 6.0% in 2020, with annual average percentage change of 3.0% (95% CI: 2.3% to 3.7%). Prevalence of CKD stages 3 and above was 4.8% in 2020. Higher CKD prevalence was observed in regional and remote areas compared with major cities, and among individuals in the most socioeconomically disadvantaged quintiles. Sensitivity analysis indicated minor impacts from data exclusions and methodological choices.

Conclusions: CKD prevalence in WA has been steadily increasing, reflecting broader Australian trends. The study highlights significant disparities in CKD prevalence based on age, socioeconomic status and geographic remoteness.

查看原文本刊更多论文

求助全文

约1分钟内获得全文求助全文

来源期刊

BMJ Open MEDICINE, GENERAL & INTERNAL-

CiteScore

4.40

自引率

3.40%

发文量

4510

审稿时长

2-3 weeks

期刊介绍： BMJ Open is an online, open access journal, dedicated to publishing medical research from all disciplines and therapeutic areas. The journal publishes all research study types, from study protocols to phase I trials to meta-analyses, including small or specialist studies. Publishing procedures are built around fully open peer review and continuous publication, publishing research online as soon as the article is ready.